Derek Pantiel, DPM
Primary Podiatric Medicine · Burgaw, NCNPI 1528353638
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.2% of the total across 117 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,128 and has fallen 52.4% since, to $537 in 2025.
Across 117 payments — averaging $32.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$579
- Convatec Inc.$483
- Amgen$285
- Imbed Biosciences Inc.$253
- Organogenesis Inc.$238
- Nevro Corp.$188
- plus $2K from 27 others
What the payments were for
- Travel & lodging$3389%
- Food & beverage$3,50291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 4 | $579 |
| Convatec Inc. | 6 | $483 |
| Amgen(2 entities) | 10 | $285 |
| Imbed Biosciences Inc. | 11 | $253 |
| Organogenesis Inc. | 19 | $238 |
| Nevro Corp. | 8 | $188 |
| Epsfl, LLC | 1 | $182 |
| Paratek Pharmaceuticals, Inc. | 7 | $156 |
| Globus Medical | 2 | $154 |
| Smith+Nephew | 7 | $138 |
| Arthrosurface Incorporated | 2 | $133 |
| Melinta Therapeutics, LLC | 5 | $110 |
| Abbott | 4 | $93 |
| Nextremity Solutions Inc. | 1 | $91 |
| Linvatec Corporation | 1 | $83 |
| Medtronic | 3 | $81 |
| Stryker(2 entities) | 3 | $74 |
| Acera Surgical, Inc. | 1 | $74 |
| Forma Medical | 1 | $70 |
| AbbVie | 4 | $61 |
| Vertex | 2 | $43 |
| Tricoast Surgical Solutions LLC | 2 | $43 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $39 |
| Bioventus LLC | 1 | $33 |
| Mimedx Group, Inc. | 1 | $29 |
| Zimmer Biomet | 1 | $29 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| Solventum Corporation | 1 | $15 |
| Acell, Inc. | 1 | $14 |
| GRT US Holding, Inc. | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $11 |
| Merck | 1 | $11 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$564
- InnovaMatrix AC$312
- Senza$130
- HemiCAP MTP Resurfacing$125
- KRYSTEXXA$124
- AQUACEL AG$119
- PuraPly$114
How this compares
$3,840 in reported general payments places this provider in the 80th percentile of 64 primary podiatric medicine providers in North Carolina.
See all primary podiatric medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 11 | $14,867 |
| Ciclopirox | 116 | $5,053 |
| Calcipotriene | 14 | $4,648 |
| Piroxicam | 15 | $4,527 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 25 | $3,975 |
| Ammonium Lactate | 111 | $2,987 |
| Ketoconazole | 105 | $2,559 |
| Mupirocin | 138 | $972 |
| Gabapentin | 64 | $560 |
| Diclofenac Sodium | 12 | $472 |
| Triamcinolone Acetonide | 14 | $329 |
| Doxycycline Monohydrate | 20 | $304 |
| Cephalexin | 51 | $273 |
| Clindamycin Hcl | 28 | $157 |
| Methylprednisolone | 30 | $137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLCJublia | $21 | $14,86711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 64 primary podiatric medicine providers in North Carolina.
Other primary podiatric medicine in Burgaw
- Ashma DavidsonStatesville$32K
- Joseph KiblerSupply$23K
- Jacob PaniciCary$13K
- Ythan WebsterNew Bern$10K
- Jon StancilGreenville$9K
- Kevin McDonaldConcord$8K
- Eric WardMatthews$7K
- Clark BrackneyGreensboro$7K
- Amy PitzerGreenville$7K
- Rose SoutherlandWilmington$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.